Incannex Healthcare Limited logo

Incannex Healthcare Limited

ASX:IHL.AX

Overview | Financials
Company Name Incannex Healthcare Limited
Symbol IHL.AX
Currency AUD
Price 0.041
Market Cap 65,067,410
Dividend Yield 0%
52-week-range 0.041 - 0.28
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Joel Bradley Latham
Website https://www.incannex.com.au

An error occurred while fetching data.

About Incannex Healthcare Limited

Incannex Healthcare Limited engages in the research, development, and sale of medicinal cannabinoid and psychedelic pharmaceutical products and therapies in Australia. It offers APIRx-1801, an ultrapure tetrahydrocannabinol; APIRx-1802, an ultrapure CBD; and APIRx-1803, an ultrapure cannabigerol. The company also develops IHL-42X, which has completed Phase IIa clinical trial for obstructive

Related Stocks

Sigma Healthcare Limited logo

Sigma Healthcare Limited

SIG.AX

1.925 AUD

Mayne Pharma Group Limited logo

Mayne Pharma Group Limited

MYX.AX

4.3 AUD

Estia Health Limited logo

Estia Health Limited

EHE.AX

3.08 AUD

Opthea Limited logo

Opthea Limited

OPT.AX

0.84 AUD

Neuren Pharmaceuticals Limited logo

Neuren Pharmaceuticals Limited

NEU.AX

12.28 AUD

Monash IVF Group Limited logo

Monash IVF Group Limited

MVF.AX

1.205 AUD

Mesoblast Limited logo

Mesoblast Limited

MSB.AX

1.345 AUD

Oceania Healthcare Limited logo

Oceania Healthcare Limited

OCA.AX

0.665 AUD

AFT Pharmaceuticals Limited logo

AFT Pharmaceuticals Limited

AFP.AX

3.2 AUD

Regis Healthcare Limited logo

Regis Healthcare Limited

REG.AX

6.51 AUD

Financials

Numbers are in millions USD

Numbers are in millions USD